This Week in Special Situations: Adient, Boston Omaha, EnQuest, Cardinal Infrastructure, H&R REIT
Adient has $435 million of buyback capacity, equal to 38% of its market value, after adding $400 million to its repurchase program.
Adient has $435 million of buyback capacity, equal to 38% of its market value, after adding $400 million to its repurchase program.
@KrisBennatti $CENX $C $SN
It's going to be really awkward in a few weeks when the $MTUM rebalance has the momentum ETF looking like the $XLP....
Entravision $EVC is a sleeping giant
Love a good GTA VI tailwind $EVC
Rick Rule argues copper needs $250 billion of capital and says 30-year uranium contracts are reshaping mine financing.
AST SpaceMobile’s 79% decline improves its risk-reward case, but satellite deployment delays, rising costs and Blacklift commitments raise…
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone…
Remitly’s Q3 revenue growth accelerated to 22% as lower transaction losses lifted margins, while recipient-facing products build a…
Dave & Buster’s faces fourteen straight quarters of same-store sales declines, shrinking margins and a new CEO’s turnaround plan after…
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward…
Euroseas’ feeder-vessel renewals and contracted cash flow support higher 2027 earnings, while Red Sea normalization, vessel values and…
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
Curaleaf’s 11.5% senior secured bonds mature February 18, 2029.
Firefly Aerospace ended Q2 2026 with $1.5 billion backlog and a 2.49x book-to-bill ratio, adding lunar, defense and launch contracts for…
ResMed benefits as Eli Lilly-funded sleep-apnoea diagnoses expand PAP demand, while NOV’s geothermal cutters and Po Valley’s unhedged…
EuroDry shares rose more than 300% year to date as dry bulk markets strengthened, but an aging fleet, no dividend and a $20 million equity…
Kestra Medical’s growth was flattered by reserve benefits, while weak WCD compliance and Element’s Jewel patch threaten ASSURE’s advantage.
ZIM’s proposed deal carries a claimed 23% spread and 110% IRR by Q4 2026, with Q3 and Q4 dividends potentially raising returns if closing…
Turning Point Brands reaffirmed 2026 guidance after a CEO change, while ALP and FRE expansion has compressed margins through marketing and…
Micron’s customer agreements, Analog Devices’ acquisitions, Ondas’ GATE deal and Baker Hughes’ power systems position them for AI…
New Era Energy & Digital secured a 20-year Vistra power deal for 200 to 207 MW, reducing Phase 1 risk for its planned 1.4 GW West Texas AI…
Shift4 trades at 6.5x EBITDA despite 11% reported organic growth, with Shift4 Dine equipment leases cited as evidence of net-new merchant…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.